CareDx (CDNA) Launches AI-based Platform VANTx

CareDx, Inc. (NASDAQ:CDNA) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. CareDx (CDNA) Launches AI Platform VANTx On March 5, 2026, CareDx, Inc. (NASDAQ:CDNA) launched VANTx, an AI-powered, cloud-native platform designed to transform complex transplant data into actionable clinical insights. The platform, introduced at the 2026 Precision Medicine World Conference, analyzes patient cohorts, treatment trends, and real-world evidence with the help of Llama 3 and advance ...